Did You Know...
...that when IBM conducted a market study of Chester Carlson's invention in 1959, the company concluded that it would take only 5000 units of his new product to saturate the market? IBM therefore declined to be part of the new product introduction. Too bad for IBM. Carlson's invention was the xerography process, and his new product was the beginning of the Xerox Corporation. It is estimated that every day, worldwide, 3,000,000,000 copies are made!!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7235566 | Pyridinone derivatives for treatment of atherosclerosis Compounds of formula (I): are inhibitors of the enzyme Lp-PLA2 and are of use in therapy, in particular for treating atherosclerosis. ... | 06/26/2007 |
| 7232902 | Process to prepare (1-carboxymethyl)-pyrimidinone compounds The invention relates to a process for the preparation of certain pyrimidinone compounds. ... | 06/19/2007 |
| 7153861 | 5,6 -Trimethylenepyrimidin-4-one compounds Pyrimidone compounds of formula (I): are inhibitors of the enzyme Lp-PLA2 and are of use is treating atheroscelerosis. ... | 12/26/2006 |
| RE39384 | Substituted thiazolidinedione derivatives A compound of formula (I): or a tautomeric form thereof, wherein: R1 represents a hydrogen atom, C1-12 alkyl, C1-12 alkoxy, C1-12 alkylcarbonyl or arylC1-12 alky... | 11/07/2006 |
| 6953803 | Pyrimidine compounds Pyrmidinone compounds of formula (I) are inhibitors of the enzyme Lp-PLA2 and of use in therapy, in particular for treating atherosclerosis. ... | 10/11/2005 |
| D506545 | Capsule linker | 06/21/2005 |
| D501550 | Capsule | 02/01/2005 |
| D501549 | Capsule | 02/01/2005 |
| 6747030 | Piperazine derivatives as 5-HT1B antagonists Piperazine derivatives of formula(1), processes for their preparation, pharmaceutical compositions containing them in the treatment of CNS and other disorders and in their use in therapy as 5-HT1B antagonists ... | 06/08/2004 |
| 6726908 | Pharmaceutical formulation This invention relates to pharmaceutical formulations comprising amoxycillin and a salt clavulanic acid in a ratio of 14:1. ... | 04/27/2004 |
| 6559155 | Pyrimidinone derivatives for the treatment of atherosclerosis Pyrimidones of formula (I) are inhibitors of the enzyme LpPLA2 and thereof use in treating inter alia atherosclerosis, ##STR1## in which: R1 is COOH or a salt thereof, COOR10, CONR11R.sup.12, CN or CH... | 05/06/2003 |
| 6548084 | Controlled release compositions A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxetine.... | 04/15/2003 |
| 6521189 | Combined laboratory condensor and vessel connector A combined laboratory condenser and vessel connector having a conduit with an inlet/outlet adjacent its upper end with a condenser jacket around the lower part of the conduit, an upper part of the jacket formed into or provided with a connector to enable ... | 02/18/2003 |
| 6509044 | Stable, optically clear compositions A process for preparing an aqueous composition for the preparation of optically clear products, especially beverages, having enhanced stability in syrup and bioavailability for human or animal healthcare. The compositions include an oil soluble ingredient... | 01/21/2003 |
| 6491874 | Multi-limbed reaction vessel A laboratory vessel comprising two substantially cylindrical chambers with parallel longitudinal axes between their bottom and mouth openings and lower and upper conduits linking the chambers so that he contents of the vessel can flow between the first an... | 12/10/2002 |
| 6489347 | Process ##STR1## Compounds of structure (1) are obtained by reduction of compounds of the structures ##STR2## ##STR3## Compounds of structure (1), especially where Z is a hydrogen atom or a 3,4-methylenedioxyphenyl group, are important intermediates for inte... | 12/03/2002 |
| 6482960 | Process for epoxidizing substituted cyclohexanones This invention relates to a method for preparing 1-oxaspiro[2,5]-carbonitriles from ketones using spinning disc reactor technology.... | 11/19/2002 |
| 6428808 | Pharmaceutical composition prepared by addition of a flavor vehicle to a medicament The invention relates to a method for preparing a flavored liquid medicament, particularly a pediatric preparation in solid form.... | 08/06/2002 |
| 6417192 | Pyrimidinone compounds and pharmaceutical compositions containing them A group of novel pyrimidone compounds are inhibitors of the enzyme LDL PLA2 and therefore of use in treating atherosclerosis.... | 07/09/2002 |
| 6410285 | Alanyl tRNA synthetase from Streptococcus pneumoniae The invention provides alaS polypeptides and DNA (RNA) encoding alaS polypetides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing alaS polypeptides to screen for antibacterial compounds.... | 06/25/2002 |
| 6410286 | Asparaginyl tRNA synthetase from Staphylococcus Aureus The invention provides tRNA synthetase polypeptides and DNA (RNA) encoding tRNA synthetase polypetides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing tRNA synthetase polypeptide for the prote... | 06/25/2002 |
| 6391891 | Bicyclic compounds as ligands for 5-HT1 receptors The invention relates to compounds which are ligands for 5HT1, of formula (I) ##STR1## Wherein L, Q, Ra, Rb and Ry are as defined in the specification, processes for their preparation and their pharmaceutical composit... | 05/21/2002 |
| 6383473 | Solid composition for reducing tooth erosion Acidic oral compositions having reduced tooth erosion characteristics, especially acid beverages such as fruit juice drink concentrates, or oral healthcare products such as mouthwashes, are prepared by adding a calcium compound to the acid composition so ... | 05/07/2002 |
| 6358528 | Pharmaceutical formulation A tablet formulation which comprises a core containing a pharmaceutically active material containing amoxycillin and clavulanate, coated with a release retarding coating, surrounded by a casing layer which includes a second pharmaceutically active materia... | 03/19/2002 |
| 6358969 | 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants This invention provides 29-desmethylrapamycin of Formula I: ##STR1## and a pharmaceutical composition thereof.... | 03/19/2002 |
| 6355452 | Human histamine H3 gene variant-2 Human histamine H3 gene variant-2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Human histamine H3 gene variant-2 polypeptides and polynucleot... | 03/12/2002 |
| 6348578 | Apt The invention provides apt polypeptides and DNA (RNA) encoding apt polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing apt polypeptides to screen for antibacterial compounds.... | 02/19/2002 |
| 6348328 | Compounds This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the uses of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides and recombinant host cells tran... | 02/19/2002 |
| 6346397 | GyrA The invention provides gyrA polypeptides and polynucleotides encoding gyrA polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing gyrA polypeptides to screen for antibacterial compounds.... | 02/12/2002 |
| 6346392 | Polynucleotides encoding a novel glutamine transport ATP-binding protein The invention provides Glutamine Transport ATP-Binding Protein polypeptides and DNA (RNA) encoding Glutamine Transport ATP-Binding Protein polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for ut... | 02/12/2002 |
| 6345717 | Reinforced blister pack A blister pack wherein the material between the blisters is reinforced to confer rigidity relative to flexing deformation of the blister pack. The reinforcement may take the form of a reinforcing slab or sheet, or ribs in the blister pack material. The in... | 02/12/2002 |
| 6346409 | Tryptophenyl tRNA synthetase from Streptococcus pneumoniae The invention provides trpS polypeptides and DNA (RNA) encoding trpS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing trpS polypeptides to screen for antibacterial compounds.... | 02/12/2002 |
| 6344540 | PAI The invention provides pai polypeptides and DNA (RNA) encoding pai polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing pai polypeptides to screen for antibacterial compounds.... | 02/05/2002 |
| 6335424 | ribG The invention provides ribG polypeptides and polynucleotides encoding ribG polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing ribG polypeptides to screen for antibacterial compounds.... | 01/01/2002 |
| 6316025 | Swallow tablet comprising paracetamol The present invention relates to a swallow tablet or capsule formulation comprising paracetamol, sodium bicarbonate, and at least one pharmaceutically acceptable excipient.... | 11/13/2001 |
| 6310193 | MurC from Streptococcus pneumoniae The invention provides MurC polypeptides and DNA (RNA) encoding MurC polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing MurC polypeptides to screen for antibacterial compounds.... | 10/30/2001 |
| 6310192 | SigB SigB polypeptides and DNA (RNA) encoding such SigB and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such SigB for the treatment of infection, particularly bacterial infections... | 10/30/2001 |
| 6303333 | SBHWSB2: a new member of the WD40 SOCS box family SBHWSB2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing SBHWSB2 polypeptides and polynucleotides in therapy, and diagnostic assays for such.... | 10/16/2001 |
| 6299903 | Delayed release pharmaceutical formulation containing a ଲ-lactam antibiotic Pharmaceutical formulations for oral administration, comprising a matrix which comprises a ଲ-lactam antibiotic, a ଲ-lactamase inhibitor, and granules in a delayed release form dispersed within the matrix which comprise a ଲ-lactam antibio... | 10/09/2001 |
| 6300097 | Signal peptidase polypeptides of Staphylococcus aureus spsB polypeptides and DNA (RNA) encoding such spsB and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such spsB for the treatment of infection, particularly bacterial infections... | 10/09/2001 |
